Clinical trials
Chemotherapy-induced Neutropenia clinical trials
Below are recruiting chemotherapy-induced neutropenia clinical trials, each written for real people, not researchers. We’re tracking 11 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07096479Recruiting
Telpegfilgrastim to prevent low white blood cells in solid tumor patients
This trial tests a once-per-cycle injection (Telpegfilgrastim) to help keep your white blood cell count from dropping dangerously low during chemotherapy. It is for people with solid tumors who are at increased risk for neutropenia (low infection-fighting cells).
Hefei, AnhuiAges 18–70 - NCT06926751RecruitingPhase 2
Preventing low white blood cell counts in kids with solid tumors
This trial compares two drugs (Telpegfilgrastim and Filgrastim) to help prevent dangerously low white blood cell counts after chemotherapy in children and young adults with solid tumors. It's for patients who have already had this problem in a previous chemo round.
BeijingAges 6–24 - NCT05245487Recruiting
Study of blood samples in older people with relapsed lymphoma
This study looks at blood (“hematopoietic”) information in people age 60+ with relapsed B-cell non-Hodgkin lymphoma who need an additional round of treatment. It may help researchers understand changes in the body during active lymphoma therapy.
CopenhagenAges 60 years+ - NCT06537726Recruiting
Breath test for fungal infections in leukemia patients
This trial tests if a simple breath analysis can detect invasive fungal infections early in people with acute leukemia who are undergoing chemotherapy and have a low white blood cell count. Early detection could help start treatment sooner.
Zurich, Canton of ZurichAges 18 years+ - NCT06616571RecruitingPhase 4
Testing a medicine to prevent low white blood cell counts from chemo
This trial tests a new way to give a medicine that helps your body make white blood cells after chemotherapy for breast cancer. It may help prevent serious infections.
Jinan, ShandongAges 18 years+ - NCT06809101Recruiting
Home blood test monitoring for cancer patients on chemotherapy
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
Næstved, Region SjællandAges 18 years+ - NCT06857292RecruitingPhase 2
A study of a new medicine to prevent fever in children on chemotherapy
This study tests a new medicine called Telpegfilgrastim to help prevent fever from low white blood cell counts in children (14–17) with certain cancers who are getting strong chemotherapy. It aims to see if the medicine is safe and works well.
Guangzhou, GuangdongAges 14–18 - NCT07586826RecruitingPhase 2
Romiplostim N01 plus ATRA for low platelets after cancer treatment
This trial tests a combination of two drugs (romiplostim N01 and ATRA) to help raise platelet counts in people whose platelets dropped after chemotherapy for gynecologic, breast, or lung cancer—even though their cancer is now gone. Low platelets can cause bleeding problems, so this treatment aims to help your body make more platelets.
BeijingAges 18 years+ - NCT07586813RecruitingPhase 2
Romiplostim N01 Plus ATRA for Low Platelets After Gut Cancer
This trial tests a combination of two medicines (Romiplostim N01 and ATRA) to raise dangerously low platelet counts that sometimes persist after chemotherapy for digestive cancers. If your platelets stay low even after previous platelet-raising treatments, this study may help.
BeijingAges 18 years+ - NCT06245746RecruitingPhase 1
Exosomes for low blood counts after chemo in leukemia
This trial tests whether umbilical cord mesenchymal stem cell exosomes can help restore blood cell counts after chemotherapy in adults with acute myeloid leukemia who are in remission. It aims to reduce the risk of infection and bleeding while waiting for bone marrow recovery.
Wuhan, HubeiAges 18–60 - NCT07491536Recruiting
Ozone therapy for mouth sores from cancer treatment
This trial tests if adding ozone therapy to a special mouthwash routine can help heal painful mouth sores caused by chemotherapy or radiation. It is for cancer patients with mild to moderate oral mucositis.
Pavia, LombardyAges 18 years+
Hear when a new Chemotherapy-induced Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chemotherapy-induced neutropenia?
- Yes. Clin2 currently lists 11 recruiting chemotherapy-induced neutropenia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chemotherapy-induced neutropenia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chemotherapy-induced neutropenia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.